At the request of Mayo Clinic leaders, the Alumni Center team is working remotely but is checking email and telephone messages.In-person shopping for alumni merchandise on the Rochester campus is temporarily suspended. Online merchandise orders may be delayed for as long as two weeks. Thank you for your patience, understanding and ongoing support during this evolving situation.

Mayo Clinic investigators receive Eagles 5th District Cancer Telethon – Cancer Research Fund Awards

Mayo Clinic Cancer Center announced that the 2020 Eagles 5th District Cancer Telethon – Cancer Research Fund provided $400,000 to fund four fellowship awards and six pilot program awards. The Cancer Center provided an additional $80,000 to support one fellowship award and one pilot program award.

2020 fellowship awardees 

*Alexander (Alex) Baker, Ph.D. (HEMO ’20), research fellow, Division of Hematology and Medical Oncology, Mayo Clinic in Arizona, “Tetravalent Highly Targeted Immunotherapy to Treat FGFR2 Aberrant Cholangiocarcinoma”

Moritz Binder, M.D. (I ’17, HEMO ’20, HEMA ‘21)., resident, Division of Hematology, Mayo Clinic in Rochester, “Epigenomic Determinants of Acquired Therapeutic Resistance in Multiple Myeloma in the Era of Quadruplet Regimens”

Ryan Carr, M.D., Ph.D. (I ’18, HEMO ’21), resident, Division of Hematology, Mayo Clinic in Rochester, “Epigenetics of Chronic Myelomonocytic Leukemia”

Caitlin Conboy, M.D., Ph.D. (I ’19, HEMO ‘22), resident, Division of Hematology, Mayo Clinic in Rochester, “YAP Tyrosine Phosphorylation Controls Lineage Commitment in Liver Tumorigenesis”

Xinyi Tu, Ph.D. (RADO ’16), senior research fellow, Division of Oncology Research, Mayo Clinic in Rochester, “ATR Promotes Breast Cancer Metastasis”

2020 pilot program awardees

*Abd Moain (Moain) Abu Dabrh, M.B., B.Ch. (PREV ’14), Department of Family Medicine, Mayo Clinic in Florida, “BeWell360-CG Care Model: Health and Wellness Coaching to Support Care Givers of Patients Living with Advanced Cancer”

Abhishek Chandra, Ph.D. (PHYS ’16), Robert and Arlene Kogod Center on Aging, Mayo Clinic in Rochester,  “Pharmacological intervention for systemic bone loss induced by Proton Therapy”

Shiv Gupta, Ph.D. (THDC ’09), Department of Radiation Oncology, Mayo Clinic in Rochester, “Targeting NAD+ Metabolism to Promote Veliparib-Mediated Sensitization of Temozolomide Therapy in Glioblastoma”

Swaathi Jayaraman, Ph.D. (ONCL ’20), Research, Mayo Clinic Rochester, “Development of a Novel PKCβ1 and ERα Targeted PROTAC drug for the Treatment of Endocrine-Sensitive and -Resistant ER+ Breast Cancer”

Abhishek Mangaonkar, M.B.B.S. (HEMO ’19, BMTX ’20), Blood and Marrow Transplant, Mayo Clinic in Rochester, “Targeting Dendritic Cell-mediated Immune Tolerance in Chronic Myelomonocytic Leukemia”

Ryan Wagner, Ph.D. (MPET ’20), Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic in Rochester, “Probing Epigenetic Vulnerabilities in H3K36 Signaling in Cancer”

*supported by Mayo Clinic Cancer Center

 

Recommended reading

Posts about similar topics: